Follow
Lucie Berkovitch
Lucie Berkovitch
Université de Paris, Yale University
Verified email at yale.edu
Title
Cited by
Cited by
Year
Disruption of conscious access in schizophrenia
L Berkovitch, S Dehaene, R Gaillard
Trends in Cognitive Sciences 21 (11), 878-892, 2017
562017
Impaired conscious access and abnormal attentional amplification in schizophrenia
L Berkovitch, A Del Cul, M Maheu, S Dehaene
NeuroImage: Clinical 18, 835-848, 2018
522018
Why the P3b is still a plausible correlate of conscious access? A commentary on Silverstein et al., 2015
L Naccache, S Marti, JD Sitt, D Trübutschek, L Berkovitch
Cortex, 2016
392016
Disruption of conscious access in psychosis is associated with altered structural brain connectivity
L Berkovitch, L Charles, A Del Cul, N Hamdani, M Delavest, S Sarrazin, ...
Journal of Neuroscience 41 (3), 513-523, 2021
342021
Subliminal syntactic priming
L Berkovitch, S Dehaene
Cognitive psychology 109, 26-46, 2019
272019
Toward mapping neurobehavioral heterogeneity of psychedelic neurobiology in humans
F Moujaes, KH Preller, JL Ji, JD Murray, L Berkovitch, FX Vollenweider, ...
Biological psychiatry 93 (12), 1061-1070, 2023
232023
Unconscious memory suppression
A Salvador, L Berkovitch, F Vinckier, L Cohen, L Naccache, S Dehaene, ...
Cognition 180, 191-199, 2018
142018
Efficacy of psychedelics in psychiatry, a systematic review of the literature
L Berkovitch, B Roméo, L Karila, R Gaillard, A Benyamina
L'encephale 47 (4), 376-387, 2021
102021
Efficacy of transcranial direct-current stimulation in catatonia: a review and case series
A Haroche, N Giraud, F Vinckier, A Amad, J Rogers, M Moyal, L Canivet, ...
Frontiers in Psychiatry 13, 876834, 2022
92022
Efficacité des psychédéliques en psychiatrie, une revue systématique
L Berkovitch, B Roméo, L Karila, R Gaillard, A Benyamina
L'Encéphale 47 (4), 376-387, 2021
82021
Efficacy and safety of intranasal esketamine in patients with treatment-resistant depression and comorbid chronic post-traumatic stress disorder: Open-label single-arm pilot study
M Rothärmel, C Benosman, W El-Hage, C Berjamin, D Ribayrol, O Guillin, ...
Frontiers in Psychiatry 13, 865466, 2022
52022
Preserved Unconscious Processing in Schizophrenia: The Case of Motivation
L Berkovitch, R Gaillard, P Abdel-Ahad, S Smadja, C Gauthier, D Attali, ...
Schizophrenia Bulletin 48 (5), 1094-1103, 2022
32022
Hallucinogènes et culture: Une approche neuroanthropologique de l’expérience psychédélique
D Dupuis, L Berkovitch
PSN 18 (3), 37-57, 2020
22020
La schizophrénie, une affaire de société
R Gaillard, L Berkovitch, JP Olié
Bulletin de l'Académie Nationale de Médecine 202 (1-2), 127-137, 2018
22018
Storm on predictive brain: a neurocomputational account of ketamine antidepressant effect
H Bottemanne, L Berkovitch, C Gauld, A Balcerac, L Schmidt, ...
Neuroscience & Biobehavioral Reviews, 105410, 2023
12023
Human brain state dynamics reflect individual neuro-phenotypes
K Lee, JL Ji, C Fonteneau, L Berkovitch, M Rahmati, L Pan, G Repovš, ...
bioRxiv, 2023
12023
La médecine psychédélique: renouveau des traitements d’action rapide contre la dépression?
H Bottemanne, L Berkovitch, M Gasnier, L Mallet
L’Information psychiatrique 99 (10), 685-692, 2023
12023
Des techniques de neurostimulation à l’immuno-psychiatrie
L Berkovitch, C Gauthier, R Gaillard
Bulletin de l'Académie Nationale de Médecine 201 (4-6), 833-844, 2017
12017
Esketamine-induced post-traumatic stress disorder flashbacks during treatment-resistant depression indication: is it just a side effect?
M Rothärmel, L Mekaoui, F Kazour, M Herrero, EM Beetz-Lobono, ...
medRxiv, 2024.01. 09.24300998, 2024
2024
Disruption of consciousness depends on insight in OCD and on positive symptoms in schizophrenia
S Tumkaya, B Yücens, M Gündüz, M Maheu, L Berkovitch
bioRxiv, 2024.01. 02.571832, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20